• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

37
13
11
10
4

COUNTRY

11
2
1
1
1

CATEGORIES

  • 110
  • 97
  • 40
  • 37
  • 35
  • 28
  • 13
  • 12
  • 9
  • 6
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

91
171
322
377

PUBLISHED

2
17
93
377

PRODUCT TYPE

272
104
1

Search "Alzheimer Disease Therapy Area Pipeline Report" returned 377 results.

Global Alzheimer’s Disease Drugs Market & Pipeline Drugs Market Analysis to 2020

Alzheimer’s disease is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global...

July 2015
FROM

Alzheimer's Disease - Pipeline Review, H2 2014

Alzheimer's Disease - Pipeline Review, H2 2014 Summary This, ‘Alzheimer's Disease - Pipeline Review, H2 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This report...

October 2014
FROM

Alzheimer's Pipeline Drugs Review, Alzheimer's Disease Drug Market & Forecast – Global Analysis

Alzheimer's disease drug market is on the curvature stage Since 2003, there is not any single “magic bullet” launched in the market to prevent or cure it However, all current marketed products are going...

December 2013
FROM

Aricept (Alzheimer's disease) - Analysis and Forecasts to 2022

Aricept (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Aricept (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides Aricept global...

April 2012
FROM

Alzheimer's Disease - Pipeline Review, H1 2014

Alzheimer's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This...

February 2014
FROM

Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015

Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015 Summary This, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Dementia...

April 2015
FROM
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

July 2015
FROM

AAB-001 (bapineuzumab) (Alzheimer's disease) - Analysis and Forecasts to 2022

AAB-001 (bapineuzumab) (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “AAB-001 (bapineuzumab) (Alzheimer’s disease) – Analysis and Forecasts to...

April 2012
FROM

Gammagard Liquid (Alzheimer's disease) - Analysis and Forecasts to 2022

Gammagard Liquid (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Gammagard Liquid (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides...

April 2012
FROM

Namenda (Alzheimer's disease) - Analysis and Forecasts to 2022

Namenda (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Namenda (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides Namenda global...

April 2012
FROM

LY2062430 (Alzheimer's disease) - Analysis and Forecasts to 2022

LY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “LY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides LY2062430...

April 2012
FROM

US CNS Disorders Drug Pipeline Insight 2014

The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. The numbers of CNS disorders have increased at an alarming rate, while the available...

August 2014
FROM

Alzheimer's Disease - Pipeline Review, H1 2015

Alzheimer's Disease - Pipeline Review, H1 2015 Summary This, ‘Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This report...

January 2015
FROM

Proteome Sciences Plc (PRM) - Product Pipeline Analysis, 2013 Update

Summary Proteome Sciences Plc (Proteome Sciences) is a protein biomarker company. The company delivers content for personalized medicine in different areas such as biomarker assays, biomarker services,...

July 2013
FROM
Nitric Oxide - Therapeutics, Markets and Companies Nitric Oxide - Therapeutics, Markets and Companies - Product Thumbnail Image

Nitric Oxide - Therapeutics, Markets and Companies

This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Major segments of the market for nitric oxide-based...

July 2015
FROM

Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2014

Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2014 Summary This, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2014’, provides an overview of the Dementia...

August 2014
FROM

Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2014

Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2014’, provides an overview...

March 2014
FROM

Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies

This report provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immunologic Disorders, Infection,...

February 2011
FROM

Amarantus Bioscience Holdings, Inc. (AMBS) - Product Pipeline Analysis, 2013 Update

Summary Amarantus Bioscience Holdings, Inc. (Amarantus BioScience) is a biotechnology company. The company discovers and develops treatments and diagnostics for diseases associated with neurodegeneration...

August 2013
FROM

Alzheimer's Drugs Market, 2012 - 2017

Alzheimer's disease is a neurodegenerative disease of the brain which leads to loss of memory and cognitive functions With ageing world population, the number of patients suffering from Alzheimer's...

May 2013
FROM
Loading Indicator

Our Clients

Walgreen's Company Elanco Global Nu Skin Enterprises Kemin Industries, Inc. Suan Farma Inc. Metagenics, Inc.